Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Fitzgerald Kevin Joseph. Insider active across 2 companies, notably ALNYLAM PHARMACEUTICALS, INC.. In total, 41 reports have been recorded. Split: 0 buy · 28 sells. Total volume traded: €2.1m. Activity tracked since 24 June 2024. The latest transaction was disclosed on 7 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Fitzgerald Kevin Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
47 shares@ US$255.560.4% of flowCommon StockSEC:0001735276-25-000010:4
25 of 41 declarations
About Fitzgerald Kevin Joseph
Fitzgerald Kevin Joseph is a declarant who has made 35 filings in total. In his most recent filings, he sold shares of ALNYLAM PHARMACEUTICALS, INC. for a total amount of 2,139,222 EUR, with the first filing date on June 26, 2024, and the last on February 17, 2026. The filings include a sale of 595,724.43 EUR published on August 14, 2024, as well as several sales on February 17, 2026, totaling 571,762.16 EUR and 511,817.73 EUR.